Insulet (PODD) Share-based Compensation (2010 - 2026)
Insulet's (PODD) quarterly Share-based Compensation came in at $19.6 million in Q2 2026, up 335.56% on a YoY basis from $4.5 million in Q2 2025, and down 7.98% quarter-over-quarter from $21.3 million in Q1 2026.
Analysis
Insulet (PODD) Share-based Compensation (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Share-based Compensation for 17 consecutive years, with $19.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 335.56% year-over-year to $19.6 million; the trailing twelve-month figure through Jun 2026 stood at $77.9 million (up 22.1% YoY), and the FY2025 full-year result was $62.7 million, down 9.52% from the prior year.
- Share-based Compensation retreated to $19.6 million in Q2 2026 per PODD's latest filing, from $21.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $21.3 million in Q1 2026 and bottomed at $4.5 million in Q2 2025.
- Historically, Share-based Compensation has averaged $14.6 million across 5 years, with a median of $14.8 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 2900.0% in 2022, then sank 73.53% in 2025.
- Over 5 years, Share-based Compensation stood at $11.2 million in 2022, then climbed by 13.39% to $12.7 million in 2023, then jumped by 57.48% to $20.0 million in 2024, then climbed by 1.5% to $20.3 million in 2025, then declined by 3.45% to $19.6 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $19.6 million, $21.3 million, and $20.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 19.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.60 Mn |
| Mar 31, 2026 | 21.30 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 16.70 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 18.10 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Mar 31, 2024 | 14.20 Mn |
| Dec 31, 2023 | 12.70 Mn |
| Sep 30, 2023 | 10.50 Mn |
| Jun 30, 2023 | 13.10 Mn |
| Mar 31, 2023 | 12.10 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Sep 30, 2022 | 9.00 Mn |
| Jun 30, 2022 | 5.40 Mn |
| Mar 31, 2022 | 15.30 Mn |
| Dec 31, 2021 | 6.80 Mn |
| Sep 30, 2021 | 300,000.00 |